PharmaSGP Holding SE Overview
Pro stress-test →PharmaSGP Holding SE is a Germany-based pharmaceutical company that produces and develops non-chemical and over-the-counter drugs and other healthcare products. The company specializes in natural, prescription-free pharmaceuticals addressing chronic conditions, pain management, sleep disorders, and age-related ailments distributed through pharmacies and wholesalers across Germany and select European markets.
Strategic Profile
Pro stress-test →The company achieved revenue of €118.84 million in 2024, representing 17.55% year-over-year growth. PharmaSGP maintains a focused portfolio of branded OTC products with strong market positioning in the German pharmacy channel, leveraging a lean operational structure with approximately 91 employees to deliver margins above 31% EBITDA.
Competitive Landscape
Pro stress-test →PharmaSGP operates in the European OTC pharmaceutical market dominated by larger multinational players and specialized generic manufacturers. The company differentiates through its portfolio of branded natural and herbal formulations addressing underserved segments (sleep, sexual wellness, nerve pain) where it maintains relatively niche market positions. Key competitors include larger diversified pharma companies and regional specialty OTC players, though PharmaSGP's focused brand strategy and German market strength provide defensibility.
Industry Context
PharmaSGP Holding SE operates in Pharmaceutical Manufacturing - Over-the-Counter (OTC) Drugs & Specialty Generics.
Key facts
Founded: 2012 · Headquarters: Gräfelfing, Germany · Employees: 91 · Revenue: $118.84M (€) · Market cap: $324.65M